FDA recently announced that it was recommending that hydrocodone combination products be moved from Schedule III to Schedule II under the Controlled Substances Act. The placement of hydrocodone combination products in Schedule II is a great idea — for 2003. But FDA’s belated action is unlikely to have a significant impact on prescription drug abuse.
Abused Medications Come From Family, Friends
The tragedy and pervasiveness of prescription drug abuse is well-documented. According to the latest National Survey on Drug Use and Health released last week, 1.9 million Americans used prescription painkillers for a nonmedical purpose for the first time in 2012. The tireless efforts of DEA and other law enforcement agencies to address this issue are